On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Musculoskeletal synovial abnormalities and treatments

TopicLeading institutions, researchers & key papers

Musculoskeletal synovial abnormalities and treatments is a topic indexed in ScholarIQ from OpenAlex.

What is known about Musculoskeletal synovial abnormalities and treatments?

ScholarIQrecord summary

This cluster of papers focuses on the diagnosis and treatment of synovial disorders, including synovial chondromatosis, pigmented villonodular synovitis, and tenosynovial giant cell tumor. It covers various aspects such as imaging, surgical treatment, radiotherapy, arthroscopic management, bursitis, molecular pathways, and ultrasound evaluation.

How many works does Musculoskeletal synovial abnormalities and treatments have?

ScholarIQindexed works

Musculoskeletal synovial abnormalities and treatments has 61 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Musculoskeletal synovial abnormalities and treatments?

ScholarIQopenalex

The OpenAlex for Musculoskeletal synovial abnormalities and treatments is on the source record.

What are the most-cited papers on Musculoskeletal synovial abnormalities and treatments?

ScholarIQmost cited works
Association between knee inflammation and knee pain in patients with knee osteoarthritis: a systematic review
Paolo Dainese, Karsten Vanden Wyngaert, Sophie De Mits, Ruth Wittoek, Ans Van Ginckel, Patrick Calders
Osteoarthritis and Cartilage. 2021154 Citations
The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee
Brent Mollon, Adrienne Lee, Jason W. Busse, Anthony M. Griffin, Peter C. Ferguson, Jay S. Wunder, John Theodoropoulos
The Bone & Joint Journal. 2015149 Citations
Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study
M.J.L. Mastboom, Emanuela Palmerini, F.G.M. Verspoor, Anja J. Rueten‐Budde, Silvia Stacchiotti, Eric L. Staals, Gerard R. Schaap, Paul C. Jutte, Will Aston, Hans Gelderblom, Andreas Leithner, Dietmar Dammerer, Akihiko Takeuchi, Quirina C. B. S. Thio, Xiaohui Niu, Jay S. Wunder, Marta Fiocco, P. D. S. Dijkstra, Robert J. P. van der Wal, Primo Andrea Daolio, Piero Picci, Alessandro Gronchi, Stefano Ferrari, Harzem Özger, Robert G. Maki, H.W.B. Schreuder, Ingrid C.M. van der Geest, Jos A. M. Bramer, W. J. B. Mastboom, Michele Boffano, E. Goldenitsch, Domenico Andrea Campanacci, Pierluigi Cuomo, Peter C. Ferguson, Anthony M. Griffin, Ye Sun, Thomas Schubert, Ketan Patel, M.SanJulian Aranguren, A. Blancheton, F. Gouin, H. R. Dürr, Carl Ferdinand Capellen, Joseph H. Schwab, Shintaro Iwata, Oleg Vyrva, Wolfram Weschenfelder, E.H.M. Wang, Min Wook Joo, Yoon‐Koo Kang, Young Gie Chung, Walid Ebeid, Johannes Bruns, Takuya Ueda, Michiel A. J. van de Sande
The Lancet Oncology. 2019131 CitationsOPEN ACCESS
Anatomy and MR Imaging Appearances of Synovial Plicae of the Knee
Roberto García-Valtuille, Faustino Abascal, Luís Cerezal, Ana García‐Valtuille, Teresa Pereda, Ana Canga, Antonio Cruz
Radiographics. 2002125 Citations
Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in Denmark
Véra Ehrenstein, Søren Lindholt Andersen, Ibrahim Qazi, Neil Sankar, Alma B Pedersen, Robert Sikorski, John Acquavella
The Journal of Rheumatology. 2017103 Citations

Where is Musculoskeletal synovial abnormalities and treatments research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Musculoskeletal synovial abnormalities and treatments is open access?

ScholarIQopen access share
27%OPEN ACCESS
Gold
7%
Green
13%
Hybrid
7%
Bronze
0%
Closed
73%

Related on ScholarIQ

470M+ articles · 14-day free trial